Carpagnano, G.E. et al. 2022. Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management. Multidisciplinary Respiratory Medicine. 17, (Feb. 2022). DOI:https://doi.org/10.4081/mrm.2022.797.